Tantalumpentoxide as a radiopacifier in injectable calcium phosphate cements for bone substitution

Tissue Engineering - Part C: Methods

Volumn 17, Issue 9, 2011, Pages 907-913

  Hoekstra, Jan Willem M ^a   Van Den Beucken, Jeroen J J P ^a   Leeuwenburgh, Sander C G ^a   Meijer, Gert J ^a   Jansen, John A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CALCIUM PHOSPHATE; CEMENTS; COMPUTERIZED TOMOGRAPHY; INTERFACES (MATERIALS); PHOSPHATES; TANTALUM; TANTALUM OXIDES; TISSUE;

BONE SUBSTITUTES; BONE SUBSTITUTION; BONE TISSUE; CA-P CEMENTS; CALCIUM PHOSPHATE CEMENT; CT SCANNING; FEMORAL CONDYLES; FIBROUS TISSUE; IMPLANT MATERIALS; IMPLANTATION TIME; IN-VIVO; MICROCOMPUTED TOMOGRAPHY; MINERAL PHASE; NONINVASIVE TECHNIQUE; TANTALUM PENTOXIDE; VOLUMETRIC MEASUREMENT; WISTAR RAT; XRAY IMAGING;

BONE CEMENT;

RATTUS NORVEGICUS;

BONE CEMENT; CALCIUM PHOSPHATE; OXIDE; RADIOPHARMACEUTICAL AGENT; TANTALUM; TANTALUM OXIDE;

ANIMAL; ARTICLE; BONE PROSTHESIS; CHEMISTRY; FEMUR; INJECTION; MALE; MICRO-COMPUTED TOMOGRAPHY; RADIOGRAPHY; RAT; WISTAR RAT; X RAY DIFFRACTION;

ANIMALS; BONE CEMENTS; BONE SUBSTITUTES; CALCIUM PHOSPHATES; FEMUR; INJECTIONS; MALE; OXIDES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TANTALUM; X-RAY DIFFRACTION; X-RAY MICROTOMOGRAPHY;

EID: 80052250752     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2010.0742     Document Type: Article

References (44)

1. Bodde, E.W., Habraken, W.J., Mikos, A.G., Spauwen, P.H., and Jansen, J.A. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites. Tissue Eng Part A 15, 3183, 2009.
2. Ruhe, P.Q., Hedberg-Dirk, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Porous poly(DL-lactic-coglycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12, 789, 2006.
3. Heini, P.F., and Berlemann, U. Bone substitutes in vertebroplasty. Eur Spine J 10 Suppl 2, S205, 2001.
4. LeGeros, R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop 395, 81, 2002.
5. Ruhe, P.Q., Wolke, J.G.C., Spauwen, P.H.M., and Jansen, J.A. Calcium phosphate ceramics for bone tissue engineering. In: Bronzino, J.D., ed. The Biomedical Engineering Handbook, Third Edition. London: Taylor & Francis Group, LLC, 2006, pp. 38-1-38-18.
6. Link, D.P., van den Dolder, J., van den Beucken, J.J.J.P., Wolke, J.G.C., Mikos, A.G., and Jansen, J.A. Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles. Biomaterials 29, 675, 2008.
7. Ginebra, M.P., Albuixech, L., Fernandez-Barragan, E., Aparicio, C., Gil, F.J., San, R.J., Vazquez, B., and Planell, J.A. Mechanical performance of acrylic bone cements containing different radiopacifying agents. Biomaterials 23, 1873, 2002.
8. Hernandez, L., Fernandez, M., Collia, F., Gurruchaga, M., and Goni, I. Preparation of acrylic bone cements for vertebroplasty with bismuth salicylate as radiopaque agent. Biomaterials 27, 100, 2006.
9. Khairoun, I., Boltong, M.G., Driessens, F.C., and Planell, J.A. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 38, 356, 1997.
10. Kobayashi, N., Ong, K., Villarraga, M., Schwardt, J., Wenz, R., Togawa, D., Fujishiro, T., Turner, A.S., Seim, H.B., 3rd, and Bauer, T.W. Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model. J Biomed Mater Res A 81, 838, 2007.
11. Wang, X., Ye, J., and Wang, Y. Influence of a novel radiopacifier on the properties of an injectable calcium phosphate cement. Acta Biomater 3, 757, 2007.
12. Kallai, I., Mizrahi, O., Tawackoli, W., Gazit, Z., Pelled, G., and Gazit, D. Microcomputed tomography-based structural analysis of various bone tissue regeneration models. Nat Protoc 6, 105, 2011.
13. Baroth, S., Bourges, X., and Fellah, B.H., and Daculsi, G. Radiopaque strategy for bone injectable substitute. Key Eng Mater 361-363, 39, 2008.
14. Chan, D.C., Titus, H.W., Chung, K.H., Dixon, H., Wellinghoff, S.T., and Rawls, H.R. Radiopacity of tantalum oxide nanoparticle filled resins. Dent Mater 15, 219, 1999.
15. Harling, R.J. Tantalum biocompatibility. Literature review on tantalum in medical applications. Internet Communication: Available at www.x-medics.com/ tantalum-biocompatibility .htm, 2002.
16. Leng, Y.X., Chen, J.Y., Yang, P., Sun, H., Wang, J., and Huang, N. The biocompatibility of the tantalum and tantalum oxide films synthesized by pulse metal vacuum arc source deposition. Nucl Instr Meth Phys Res B 242, 30, 2006.
17. Moeggenborg, K.J., Grunbine, S.K., and Laurent, M. United States of America Patent: 20060286136, 2006.
18. Persson, C., Guandalini, L., Baruffaldi, F., Pierotti, L., and Baleani, M. Radiopacity of tantalum-loaded acrylic bone cement. Proc Inst Mech Eng H 220, 787, 2006.
19. Schulz, H., Mä dler, L., Pratsinis, S.E., Burtscher, P., and Moszner, N. Transparant nanocomposites of radiopaque, flame-made Ta2O5/SiO2 particles in an acrylic matrix. Adv Funct Mater 15, 830, 2005.
20. Zitter, H., and Plenk, H., Jr. The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility. J Biomed Mater Res 21, 881, 1987.
21. Wenisch, S., Stahl, J.P., Horas, U., Heiss, C., Kilian, O., Trinkaus, K., Hild, A., and Schnettler, R. In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: fine structural microscopy. J Biomed Mater Res A 67, 713, 2003.
22. Hungaro Duarte, M.A., de Oliveira El Kadre, G.D., Vivan, R.R., Guerreiro Tanomaru, J.M., Tanomaru Filho, M., and de Moraes, I.G. Radiopacity of portland cement associated with different radiopacifying agents. J Endod 35, 737, 2009.
23. Bodde, E.W., Habraken, W.J., Mikos, A.G., Spauwen, P.H., and Jansen, J.A. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites. Tissue Eng Part A 15, 3183, 2009.
24. Ruhe, P.Q., Hedberg-Dirk, E.L., Padron, N.T., Spauwen, P.H., Jansen, J.A., and Mikos, A.G. Porous poly(DL-lactic-coglycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 12, 789, 2006.
25. Heini, P.F., and Berlemann, U. Bone substitutes in vertebroplasty. Eur Spine J 10 Suppl 2, S205, 2001.
26. LeGeros, R.Z. Properties of osteoconductive biomaterials: calcium phosphates. Clin Orthop 395, 81, 2002.
27. Ruhe, P.Q., Wolke, J.G.C., Spauwen, P.H.M., and Jansen, J.A. Calcium phosphate ceramics for bone tissue engineering. In: Bronzino, J.D., ed. The Biomedical Engineering Handbook, Third Edition. London: Taylor & Francis Group, LLC, 2006, pp. 38-1-38-18.
28. Link, D.P., van den Dolder, J., van den Beucken, J.J.J.P., Wolke, J.G.C., Mikos, A.G., and Jansen, J.A. Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles. Biomaterials 29, 675, 2008.
29. Ginebra, M.P., Albuixech, L., Fernandez-Barragan, E., Aparicio, C., Gil, F.J., San, R.J., Vazquez, B., and Planell, J.A. Mechanical performance of acrylic bone cements containing different radiopacifying agents. Biomaterials 23, 1873, 2002.
30. Hernandez, L., Fernandez, M., Collia, F., Gurruchaga, M., and Goni, I. Preparation of acrylic bone cements for vertebroplasty with bismuth salicylate as radiopaque agent. Biomaterials 27, 100, 2006.
31. Khairoun, I., Boltong, M.G., Driessens, F.C., and Planell, J.A. Effect of calcium carbonate on clinical compliance of apatitic calcium phosphate bone cement. J Biomed Mater Res 38, 356, 1997.
32. Kobayashi, N., Ong, K., Villarraga, M., Schwardt, J., Wenz, R., Togawa, D., Fujishiro, T., Turner, A.S., Seim, H.B., 3rd, and Bauer, T.W. Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model. J Biomed Mater Res A 81, 838, 2007.
33. Wang, X., Ye, J., and Wang, Y. Influence of a novel radiopacifier on the properties of an injectable calcium phosphate cement. Acta Biomater 3, 757, 2007.
34. Kallai, I., Mizrahi, O., Tawackoli, W., Gazit, Z., Pelled, G., and Gazit, D. Microcomputed tomography-based structural analysis of various bone tissue regeneration models. Nat Protoc 6, 105, 2011.
35. Baroth, S., Bourges, X., and Fellah, B.H., and Daculsi, G. Radiopaque strategy for bone injectable substitute. Key Eng Mater 361-363, 39, 2008.
36. Chan, D.C., Titus, H.W., Chung, K.H., Dixon, H., Wellinghoff, S.T., and Rawls, H.R. Radiopacity of tantalum oxide nanoparticle filled resins. Dent Mater 15, 219, 1999.
37. Harling, R.J. Tantalum biocompatibility. Literature review on tantalum in medical applications. Internet Communication: Available at www.x-medics.com/ tantalum-biocompatibility .htm, 2002.
38. Leng, Y.X., Chen, J.Y., Yang, P., Sun, H., Wang, J., and Huang, N. The biocompatibility of the tantalum and tantalum oxide films synthesized by pulse metal vacuum arc source deposition. Nucl Instr Meth Phys Res B 242, 30, 2006.
39. Moeggenborg, K.J., Grunbine, S.K., and Laurent, M. United States of America Patent: 20060286136, 2006.
40. Persson, C., Guandalini, L., Baruffaldi, F., Pierotti, L., and Baleani, M. Radiopacity of tantalum-loaded acrylic bone cement. Proc Inst Mech Eng H 220, 787, 2006.
41. Schulz, H., Mä dler, L., Pratsinis, S.E., Burtscher, P., and Moszner, N. Transparant nanocomposites of radiopaque, flame-made Ta2O5/SiO2 particles in an acrylic matrix. Adv Funct Mater 15, 830, 2005.
42. Zitter, H., and Plenk, H., Jr. The electrochemical behavior of metallic implant materials as an indicator of their biocompatibility. J Biomed Mater Res 21, 881, 1987.
43. Wenisch, S., Stahl, J.P., Horas, U., Heiss, C., Kilian, O., Trinkaus, K., Hild, A., and Schnettler, R. In vivo mechanisms of hydroxyapatite ceramic degradation by osteoclasts: fine structural microscopy. J Biomed Mater Res A 67, 713, 2003.
44. Hungaro Duarte, M.A., de Oliveira El Kadre, G.D., Vivan, R.R., Guerreiro Tanomaru, J.M., Tanomaru Filho, M., and de Moraes, I.G. Radiopacity of portland cement associated with different radiopacifying agents. J Endod 35, 737, 2009.